HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James J Hanyok Selected Research

edoxaban

10/2015Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial.
11/2013Edoxaban versus warfarin in patients with atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James J Hanyok Research Topics

Disease

2Stroke (Strokes)
10/2015 - 11/2013
2Atrial Fibrillation
10/2015 - 11/2013
2Embolism (Embolus)
10/2015 - 11/2013
1Myocardial Infarction
10/2015
1Hemorrhage
11/2013
1Atherosclerotic Plaque (Atheroma)
03/2006
1Atherosclerosis
03/2006
1Heart Failure
06/2002

Drug/Important Bio-Agent (IBA)

2Warfarin (Coumadin)FDA LinkGeneric
10/2015 - 11/2013
2edoxabanIBA
10/2015 - 11/2013
1Vitamin KFDA Link
10/2015
1Factor Xa (Coagulation Factor Xa)IBA
10/2015
1AnticoagulantsIBA
10/2015
1pactimibeIBA
03/2006
1Vasopeptidase InhibitorsIBA
06/2002
1omapatrilatIBA
06/2002
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
06/2002